Gaijin Panty

Biotechnology Instrumentation Market research report is a professional and extensive market data. The Report provides a basic overview of the Biotechnology Instrumentation Market including definitions, classifications, applications and chain structure. This report provides analysis for the international …

Ishares Nasdaq Biotechnology logo Amussen Hunsaker Associates LLC raised its position in shares of Ishares Nasdaq Biotechnology (NASDAQ:IBB) by 198.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,514 shares of the …

Puma Biotechnology (PBYI) has entered into an agreement for Pint Pharma to commercialize NERLYNX in Argentina, Brazil, Chile, Colombia, Mexico and the rest of Latin America. NERLYNX is not approved for commercialization outside the US. Pint Pharma will be responsible for seeking the requisite …

The competition was strong for #BIO2018’s Buzz of BIO contest but only one winner from each category, “Technologies of Tomorrow” and “Pipelines of Promise,” could come out on top of the voting. Avery Therapeutics took the crown for “Technologies of Tomorrow” and biomarck Pharmaceuticals achieved the top spot in the “Pipelines of Promise” category. Buzz of BIO winners receive one complimentary Convention Access & Partnering registration pass and the opportunity to give a Company Presentation in front of industry colleagues at BIO’s convention.

Both companies, along with many others, will be presenting at the 2018 BIO International Convention in Boston this June 4-7, an opportunity conducive to increasing visibility and attracting more partners at the event. Presenting biotechs pitch their companies’ stories, pipelines, and objectives to a global audience representing more than 70 countries. Company Presentations are open to all BIO International Convention registrants.

“Technologies of Tomorrow” winner, Avery Therapeutics, is a startup company dedicated to advancing tissue-engineered therapeutics to treat diseases and injuries to human muscle. Avery’s novel engineered tissue platform enhances cell therapy delivery by targeting the root cause of degenerative disease. Avery’s MyCardia™ treatment for heart failure demonstrated pre-clinical functional improvements anticipated to translate to a significant improvement in quality of life.

Winner of the “Pipelines of Promise” category, biomarck Pharmaceuticals, is developing its lead compound, BIO-11006 for non-small cell lung cancer (NSCLC) and acute respiratory distress syndrome (ARDS). They have active INDs for both indications and are conducting Phase 2 clinical studies in patients with NCSLC and ARDS in 2017/2018.

BIO is still accepting applications to deliver a company presentation. Gain access to business development executives, investors, research analysts, policy makers, and media, and get more activity in BIO One-on-One Partnering™ by presenting. Click here to learn more about Company Presentations and for application instructions.

WASHINGTON–(BUSINESS WIRE)–The BIO International Convention, the world’s premier life sciences event, will return to the Boston Convention & Exhibition Center, June 4-7, to celebrate 25 years of advocacy and innovation. Hosted by the Biotechnology Innovation Organization (BIO), the 2018 …

The “Today’s Homeowner” crew helped AJ and Alani Rodgers turn their teenage boys’ “lockerroom-decor” bathroom into a retreat. We covered these projects in this episode: Painting the walls Framing the mirror Building a window seat Glazing the woodwork Replacing cabinet hardware Replacing plumbing fixtures Check out the Easy, Beautiful Bathroom episode article for more information […]

Puma Biotechnology logo Nicholas Investment Partners LP cut its holdings in Puma Biotechnology Inc (NASDAQ:PBYI) by 48.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,453 shares of …

We’re a country that is generations from being on the farm, for the most part. And most people just don’t know that much about where their food comes from. Because of this, there are a lot of myths, misconceptions, and flat out rumors about how farmers manage their farms. There are claims that farmers are forced to buy certain seeds, or buy from a certain company. The reality is that farmers decide for themselves what to grow each year.  They choose what to do.  And those decisions are made based upon a variety of factors, including economics, weather, land, and global market demand.

GMO Answers has asked farmer and GMO Answers volunteer expert Brandon Hunnicutt to explain how he makes these decisions. Brandon lives on a piece of land that his family has farmed for over 100 years. He is passionate about agriculture, whether he’s trying to raise the next big crop, utilizing the next big technological advance, researching a product to make his crops healthier or more productive, or trying to protect agriculture from those who want to farm it.

In a new post on the GMO Answers Medium page, he talks about his options. And yes, those options include growing genetically modified seeds. Ultimately, the decision is his. He and his family have many questions to ask, and answer:

Our plan is developed in many the same ways a home gardener would develop their plan. We consider:

·         What crops do I like?

·         What grows well in my area?

·         Were there problems (disease, weeds, insects) last year that may be a problem this year?

·         Do I need to rotate crops to help with soil health?

·         Is there something new I would like to try?

·         Where am I going to purchase my seeds?

·         Do I have a preferred place to buy seeds or do I want to try something new?

Ultimately, their goal with all of these decisions is to produce the highest quality crop they can, free from pest damage and disease – just like any home gardener would do. Learn more about Brandon, and his decision making process, at the GMO Answers Medium page.

As BIO celebrates its 25-year anniversary, the upcoming BIO International Convention June 4-7 at the Boston Convention and Exhibition Center will highlight the organization’s past and imagine the future. With the theme and tagline, “make history”, BIO 2018 will be remembered for its high-profile speakers, over 16,000 attendees, 1,800 exhibitors, record breaking partnering meetings, stellar education program, global pavilions and super fun networking events.

The first keynote speaker was announced today: TV’s Robin Roberts. A well-known broadcast journalist, Roberts has conducted interviews with countless newsmakers, musicians, authors, athletes and celebrities. She was diagnosed with breast cancer in June 2007. Five years later after beating cancer, she was diagnosed with myelodysplastic syndrome (MDS), a rare disease of the blood and bone marrow once known as pre-leukemia. Roberts underwent a bone marrow transplant in September 2012 and has become an outspoken advocate for bone marrow donations and blood cancer research. The keynote session, will be held Tuesday, June 5 from 9-10:30 AM (EST).

Why Boston?

As the world’s epicenter of biotechnology innovation, Boston – which last hosted BIO in 2012 – is the prime location for BIO 2018. The city is home to nearly 1,000 biotech companies, academic centers, hospitals and life science centers advancing breakthrough research and product development. Over the last decade, Massachusetts has become a powerhouse for industry growth, with a 30 percent increase in jobs and no signs of slowing down. At last year’s convention, Governor Charlie Baker unveiled a 5-year, $500 million plan to increase infrastructure, research and development, and workforce training to continue building upon Massachusetts’ scientific excellence.

What to Expect

Registration is open for this year’s event, which promises to be the most comprehensive biotech convention in the world. BIO 2018 will offer:

• Nineteen educational tracks, covering all sectors of biotechnology including genome editing, opioids, digital health, oncology, personalized medicine, food and agriculture and more.
• Discussions by top thought leaders from:
  

  • Bill and Melinda Gates Foundation – Dr. Penny Heaton and Dr. Susan Desmond-Hellmann
  • Food and Drug Administration – Dr. Scott Gottlieb
  • Novartis – Dr. Jay Bradner
  • Merck – Kevin Ali, Dr. Christine Brennan, Dr. Julie Gerberding and Michael Nally
  • Sanofi – Dr. Heather Bell, Dr. Justin Huddleson, Dr. Adam Keeney and Stephen Meunier
  • Kraft Group and New England Patriots President – Jonathan Kraft

• Engaging exhibits such as the Patient Advocacy Pavilion, Emerging Innovators Zone, Digital Health Zone, and Start-Up Stadium – a “Shark Tank”-like program where startups present to leading subject-matter experts in the industry.

Networking

BIO 2018 will play host to countless networking and partnering opportunities including receptions on Monday and Wednesday and Hospitality receptions on the exhibit floor at the end of the day on Tuesday.

Party-goers for Wednesday’s evening reception will be entertained by no other than DIANA ROSS!

Receptions are great for networking but BIO’s proprietary One-on-One Partnering™ program holds the key to making the right connections and building relationships-and it opens next week. The system allows attendees to identify potential partners and schedule meetings prior to the conference. In 2017, there were over 41,400 individual meetings held over the course of four days. Anyone registered for Convention Access + Partnering can use the system and the chances for getting the meetings you want improve the earlier you log in and set up your company profile.

Scheduling

With proper planning, in just four critical days, you can set up a full year of business connections, partnering possibilities and exposure to many innovations for the future of biotech. BIO offers a variety of programming, connection points and networking resources to ensure success. Begin by outlining your organization’s objectives (and a few personal ones too) and start evaluating how you can make the most of your time at BIO.

All of this points to Boston as the place to be from June 4-7 for you to “make history” with promising partnerships.  To learn more about the event and available registration packages, please visit convention.bio.org/register.

Like many mothers, Allison Bernstein was overwhelmed with the information about what makes food safe. So overwhelmed, in fact, she thought “everything was killing us, and everything was destroying her.”

However, that all changed when she started working at a toxicology lab, where the science around biotechnology cannot be misconstrued by the internet or the organic industry.

In a recent piece for the Lansing State Journal, reporter RJ Wolcott profiles Bernstein’s journey from science skeptic, influenced by misinformation perpetuated by the organic industry, to science advocate, engaging in healthy debate and providing education on biotechnology and GMOs through her blog Mommy, Ph.D.

Even in the wake of threats against her and her family, Bernstein continues to be a vocal critic of unscientific practices.

Alison Bernstein used to be a “fear-based mom.”

In the documentary “Science Moms,” she described feeling overwhelmed with dread that the food she brought from the store could have life-long impacts on her daughter.

Then, Bernstein got a job in a toxicology lab at Emory University in Atlanta.

“I thought I was going to go there and find out that everything was killing us and everything was destroying her.”

Instead, the experience helped her put exposure to various chemicals into the larger context of everyday life. For instance, she said, the same chemical that prompted outrage over its use as an artificial coloring in pumpkin spice lattes – 4-MEI – is naturally present in coffee, soy sauce, beer and bread.

Bernstein, who now works as an assistant professor of translational science and molecular medicine at Michigan State University’s College of Human Medicine in Grand Rapids, didn’t find that level of nuance and understanding online.

She found bloggers relying on their experience as mothers to make unscientific claims about the dangers of genetically engineered crops and vaccines.

“Pseudoscience and anti-science stuff provides really simple, easy answers,” Bernstein said. “It gives a clear boogeyman, like GMOs or vaccines, and a clear solution, and that is much easier to deal with.”

She decided to reserve a tongue-in-cheek name on Facebook for her own blog – Mommy, PhD. – in 2011, though she didn’t start writing it in earnest until a few years later.

“I welcome discussion,” Bernstein wrote under her rules section. “In fact, I love a good discussion about science. But I do not tolerate trolls.”

Challenging unscientific views online comes at a cost.

When Bernstein started blogging about GMOs and vaccines, she got messages wishing cancer upon her and her children. She asked her family to restrict their social media visibility out of fear that they would get harassed, too.

It hasn’t stopped her from being a vocal critic of unscientific practices. She sees real value in being both a mother with relatable interests who also can speak with authority on these topics.

“I think most people don’t have time to spend time reading the scientific literature, but it helps to know someone who is like them, someone they can trust, someone who is an expert also, has formed an opinion about something and can back it up if asked.”

Bernstein was asked by her Pilates instructor last fall about a poster hung inside the studio that highlighted produce with purportedly high levels of pesticides. Her instructor asked whether she trusted it. Bernstein said no, and after a two-minute conversation about why not, the instructor took the poster down.

“She didn’t want piles of data,” Bernstein said. “She just wanted to know that someone she knows and trusts, who is a scientist and has some knowledge of this, doesn’t trust it.”

Bernstein joined her fellow Science Moms last week for the first Michigan screening of the film at MSU.

Wearing a blue Science Moms necklace, she sat in front of a classroom of two dozen people and talked about her experiences bringing scientific understanding into online debates.

“She brings that science background and expertise but also communicates it so well,” said Natalie Newell, the filmmaker behind “Science Moms”. “I’m not an expert in science at all, but I can listen to her and understand what she’s saying and she’s a person I wanted in front of parents who might have fears.”

Bernstein also gets her daughters involved with her work. She uses her oldest’s Legos for comics, most recently introducing the villain Sue Doe Syence.

Her daughter even drew her a picture of a troll that she could use whenever someone attempted to subvert the comment section of the blog.

“Don’t feed the trolls” is one of Bernstein’s favorite adages.

One incident from 2015 was particularly upsetting for Bernstein and fellow science mom Kavin Senapathy, an author and co-executive director of March Against Myths, an organization that fights against misinformation.

Both of them are “Buffy the Vampire Slayer” fans. Sarah Michelle Gellar, who played Buffy on the television show, was among several celebrities who came out in favor of labeling GMOs out of concern for their potential impact on consumers.

Bernstein and Senapathy were among several scientists, farmers and science writers who put out an open letter in response. It read, in part, “Please, don’t co-opt motherhood and wield your fame to oppose beneficial technologies like genetic engineering.”

The National Academies of Sciences, Engineering and Medicine released a far-reaching report the following year that reaffirmed, in part, “no substantiated evidence that foods from (genetically engineered) crops were less safe than foods from non-GE crops.”

Still, the labeling GMOs movement persists, and labels saying that no GMOs were used in a given product can be found on products ranging from Cheerios to Ben and Jerry’s ice cream.

Worse than the anti-GMO advocates are the anti-vaccine proponents, Bernstein said. It was the measles outbreak in California in 2015 that pushed her to be more vocal as a mother and scientist.

She remembers being a graduate student at Washington University when Jenny McCarthy first started propagating the idea that vaccines were dangerous and linked to autism in the mid-to-late 2000s. The research underpinning McCarthy’s view has long since been discredited, but anti-vax beliefs continue to persist online.

Had scientists come out strongly against those claims earlier, maybe it wouldn’t have gotten so popular, Bernstein said.

Kristina Kamensky, a PhD candidate in mechanical engineering at MSU who came to the film screening, knows that challenge first-hand. Her father frequently uses cayenne pepper mixes rather than prescribed blood thinners. He doesn’t trust conventional medicine, which is concerning to Kamensky. Seeing Bernstein and her fellow Science Moms tackle misinformation is heartening, she said.

“It’s encouraging that success can happen after brief conversations with people.”